Ovarian cancer group:None

5 trials

Sponsors

The First Affiliated Hospital of Zhengzhou University, Second Xiangya Hospital of CSU, Suining Central Hospital, National Cancer Center/National Clinical Research Center for Cancer/Cancer Hospital & Shenzhen Hospital, Chinese Academy of Medical Sciences and Peking Union Medical College, ShenZhen, Yuebei People’s Hospital

Conditions

Benign ovarian tumo and ovarian cancerOvarian CancerOvarian cancerovarian cancer

Early Phase 1

Study on the Regulation of SNRPC Gene by Clock/BMAL1 in Modulating Immune Infiltration in Ovarian Cancer

Active, not recruitingChiCTR2500105052

Suining Central HospitalOvarian Cancer

Start: 2025-06-30Updated: 2025-06-30

The role of MRD in predicting ovarian cancer recurrence and chemosensitivity

RecruitingChiCTR2500111197

National Cancer Center/National Clinical Research Center for Cancer/Cancer Hospital & Shenzhen Hospital, Chinese Academy of Medical Sciences and Peking Union Medical College, ShenZhenovarian cancer

Start: 2022-11-16Updated: 2025-11-03

Unknown Phase

A comparative study of exosomal protein markers in ovarian cancer and normal human ovarian tissues

Active, not recruitingChiCTR2100053817

The First Affiliated Hospital of Zhengzhou Universityovarian cancer

Start: 2022-01-01Updated: 2022-10-24

Development of new diagnostic liquid biopsy technology for ovarian cancer

Active, not recruitingChiCTR2500097809

Second Xiangya Hospital of CSUOvarian cancer

Start: 2025-03-01Updated: 2025-03-03

The diagnosis for early ovarian cancer from the detection of AMH, D-dimer combined with serum CA125 and HE4.

Active, not recruitingChiCTR2600122128

Yuebei People’s HospitalBenign ovarian tumo and ovarian cancer

Start: 2026-04-09Updated: 2026-04-14